Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: TSE:CXR
- CUSIP: N/A
- Web: concordiarx.com
- Market Cap: C$88.38 million
- Outstanding Shares: 51,089,000
- 50 Day Moving Avg: C$1.81
- 200 Day Moving Avg: C$2.45
- 52 Week Range: C$1.41 - C$28.35
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: C$748.18 million
- Price / Sales: 0.12
- Book Value: C($8.59) per share
- Price / Book: -0.20
- EBIDTA: C$380.7 million
- Net Margins: -49.09%
- Return on Assets: -8.60%
- Average Volume: 242,392 shs.
- Short Ratio: 0.8
Frequently Asked Questions for Concordia International Corp (TSE:CXR)
What is Concordia International Corp's stock symbol?
Concordia International Corp trades on the Tornton Stock Exchange (TSX) under the ticker symbol "CXR."
How often does Concordia International Corp pay dividends? What is the dividend yield for Concordia International Corp?
Concordia International Corp announced a quarterly dividend on Wednesday, July 13th. Shareholders of record on Friday, July 29th will be given a dividend of 0.075 per share on Friday, July 29th. This represents a $0.30 dividend on an annualized basis and a yield of 17.34%. The ex-dividend date of this dividend is Wednesday, July 13th. View Concordia International Corp's Dividend History.
How were Concordia International Corp's earnings last quarter?
Concordia International Corp (TSE:CXR) announced its earnings results on Thursday, August, 13th. The company reported $1.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.06 by $0.02. The firm earned $95.34 million during the quarter, compared to analyst estimates of $87.41 million. View Concordia International Corp's Earnings History.
Where is Concordia International Corp's stock going? Where will Concordia International Corp's stock price be in 2017?
5 brokerages have issued 1 year target prices for Concordia International Corp's shares. Their forecasts range from C$13.50 to C$17.00. On average, they anticipate Concordia International Corp's stock price to reach C$14.83 in the next twelve months. View Analyst Ratings for Concordia International Corp.
Who are some of Concordia International Corp's key competitors?
Some companies that are related to Concordia International Corp include NewCastle Gold Ltd (NCA), Mandalay Resources Corp. (MND), Street Capital Group (SCB), Alexco Resource Corp. (AXR), Xtreme Drilling Corp (XDC), NGEx Resources (NGQ), Nautilus Minerals (NUS), Platinum Group Metals Limited (PTM), Granite Oil Corp (GXO), Urthecast Corp (UR), North American Energy Partners (NOA), Cipher Pharmaceuticals (CPH), Stuart Olson (SOX), Black Diamond Group Ltd (BDI), CENTRIC HEALTH Corp (CHH), PHX Energy Services Corp (PHX), Newalta (NAL) and Brick Brewing Co. Limited (BRB).
Who are Concordia International Corp's key executives?
Concordia International Corp's management team includes the folowing people:
- Jordan M. Kupinsky J.D., Chairman of the Board
- Wayne Kreppner, President, Chief Operating Officer
- Allan Oberman, Chief Executive Officer, Director
- David J. Price, Chief Financial Officer
- Graeme Duncan, President - Company's International Segment
- Arijit Mookerjee, Managing Director, Chief Financial Officer - Operations
- Adeel Ahmad, Chief Financial Officer of AMCo
- Francesco Tallarico, Chief Legal Officer and Secretary
- Patrick Vink M.D., Director
- Douglas N. Deeth, Independent Director
How do I buy Concordia International Corp stock?
Shares of Concordia International Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Concordia International Corp's stock price today?
MarketBeat Community Rating for Concordia International Corp (TSE CXR)MarketBeat's community ratings are surveys of what our community members think about Concordia International Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Concordia International Corp stock can currently be purchased for approximately C$1.73.
Consensus Ratings for Concordia International Corp (TSE:CXR) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||5 Sell Ratings|
|Consensus Rating:||Sell (Score: 1.00)|
|Consensus Price Target: ||C$14.83|
Analysts' Ratings History for Concordia International Corp (TSE:CXR)
(Data available from 6/27/2015 forward)
|2/9/2017||TD Securities||Downgrade||Hold -> Reduce|
|12/8/2016||Royal Bank Of Canada||Downgrade||Sector Perform -> Underperform|
|11/7/2016||Bloom Burton||Downgrade||Hold -> Sell|
|8/15/2016||Goldman Sachs Group, Inc. (The)||Lower Price Target||C$34.00 -> C$17.00|
|8/15/2016||CIBC||Downgrade||Sector Perform -> Underperform|
|3/21/2016||Dundee Securities||Lower Price Target||C$62.00 -> C$60.00|
|9/9/2015||Canaccord Genuity||Boost Price Target||C$95.00 -> C$100.00|
Earnings History for Concordia International Corp (TSE:CXR)Earnings History by Quarter for Concordia International Corp (TSE CXR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/13/2015||Q2||$1.06||$1.04||$87.41 million||$95.34 million||View||Listen|
|8/13/2014||$0.19||($0.03)||$24.42 million||$28.49 million||View||N/A|
Earnings Estimates for Concordia International Corp (TSE:CXR)
Current Year EPS Consensus Estimate: $1.26 EPS
Dividend History by Quarter for Concordia International Corp (TSE CXR)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Concordia International Corp (TSE:CXR)Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/25/2017||Erin Colleen O'neil||Director||Sell||191||C$1.74||C$332.34|
|5/16/2017||Graeme Neville Duncan||Director||Sell||7,065||C$1.91||C$13,494.15|
|2/1/2016||Mark Laurence Thompson||Director||Buy||60||C$28.77||C$1,726.20|
|11/17/2015||Wayne Walter Kreppner||Insider||Buy||3,000||C$43.67||C$131,010.00|
|11/16/2015||Mark Laurence Thompson||Director||Buy||23,150||C$43.36||C$1,003,702.98|
|7/17/2015||Wayne Walter Kreppner||Insider||Sell||4,800||C$103.00||C$494,400.00|
|6/26/2015||Robert Steven Altman||Insider||Sell||62,500||C$93.93||C$5,870,893.75|
|5/27/2015||Saldanha Adrian De||Insider||Buy||1,000||C$80.61||C$80,610.00|
|10/31/2014||James Christopher Reebals||Director||Sell||7,500||C$37.25||C$279,360.75|
|10/30/2014||James Christopher Reebals||Director||Sell||7,500||C$37.06||C$277,926.75|
|10/29/2014||James Christopher Reebals||Director||Sell||5,000||C$37.07||C$185,336.50|
Headline Trends for Concordia International Corp (TSE:CXR)
Latest Headlines for Concordia International Corp (TSE:CXR)
Concordia International Corp (CXR) Chart for Tuesday, June, 27, 2017